Dr Eva Ehrnrooth (MD PhD) brings + 20 years of experience in Clinical Development focused on Oncology. Her expertise spans, small molecules, monoclonal antibodies and vaccines. She led global clinical development across various solid tumor indications at Boehringer-Ingelheim, Genmab and Novo Nordisk. She has a proven track record of building and leading development teams, successful BLA, fundraising and IPO.
Dr Eva Ehrnrooth, MD PhD to join One-carbon Therapeutics AB management team as interim CMO
Dr Eva Ehrnrooth (MD PhD) brings + 20 years of
